|
Baseline and 7 yr follow-up characteristics (mean ± SD) of the participants presented by the presence or absence of the metabolic syndrome (MS) as adolescents |
||||
| Baseline |
Seven Years Later |
|||
|
|
||||
| No MS |
MS |
No MS |
MS |
|
|
|
||||
| Age (y) |
8.6 ± 0.8 |
8.7 ± 0.7 |
15.2 ± 0.7 |
15.1 ± 0.7 |
| Height (cm) |
135 ± 6 |
136 ± 6 |
168 ± 5 |
170 ± 8 |
| Body Mass (kg) |
32.3 ± 7.2 |
35.7 ± 6.2 |
63.7 ± 12.9 |
83.9 ± 12.9** |
| BMI (kg/m2) |
17.6 ± 2.8 |
19.3 ± 2.0* |
22.4 ± 3.9 |
29.0 ± 4.3** |
| Body Fat (%) |
20.4 ± 7.4 |
26.0 ± 7.8* |
24.5 ± 9.3* |
36.6 ± 9.8* |
| BPsys (mmHg) |
103 ± 10 |
108 ± 10* |
114 ± 9 |
127 ± 10** |
| BPdia (mmHg) |
67 ± 8 |
68 ± 9 |
68 ± 9 |
75 ± 11 |
| Chol (mmol/L) |
4.18 ± 0.75 |
4.60 ± 0.91* |
3.77 ± 0.64 |
4.48 ± 0.78** |
| PA Score |
67 ± 29 |
49 ± 20* |
156 ± 69 |
122 ± 48** |
| VO2max (ml/kg/min) |
44.3 ± 9.0 |
35.8 ± 11.6* |
38.9 ± 10.2 |
29.7 ± 10.4** |
| VO2max (ml/kgFFM/min) |
55.4 ± 9.7 |
48.4 ± 14.5 |
51.2 ± 10.1 |
46.9 ± 10.4 |
| HDL-C (mmol/L) |
---- |
---- |
1.23 ± 0.26 |
1.01 ± 0.20** |
| Trig (mmol/L) |
---- |
---- |
0.86 ± 0.46 |
1.57 ± 0.7** |
| Glucose (mmol/L) |
---- |
---- |
4.77 ± 0.42 |
5.14 ± 0.67** |
|
* p < 0.04 MS vs. No MS at Baseline ** p < 0.002 MS vs. No MS at seven-years follow-up | ||||
McMurray et al. Dynamic Medicine 2008 7:5 doi:10.1186/1476-5918-7-5 |
||||